rhinopront syrup

contains 300 mg phenylpropanolamine and 24 mg carbinoxamine per 100 g, both chemically adsorbed on a polysulfonate ion exchange resin from which they are released in the gastro-intestinal tract. Special List (T).

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Rhinitis 10/01/1994 - "Exploratory study of the decongestive effect of Rhinopront syrup in adults and in children with acute rhinitis." 10/01/1994 - "The decongestive effect of Rhinopront syrup was assessed in 18 adults and 18 children with acute rhinitis, by comparison to a matching placebo syrup and to a commercial standard decongestant (Triaminic tablets or drops). "

Related Drugs and Biologics

1.	Nasal Decongestants (Decongestants)
2.	Tablets